{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:17:04Z","timestamp":1783005424342,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neuroscience.2026.05.044","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:32:43Z","timestamp":1780331563000},"page":"137-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cannabis for tic control: a systematic review and meta-analysis of its efficacy in Tourette syndrome management"],"prefix":"10.1016","volume":"609","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7138-8102","authenticated-orcid":false,"given":"Govind Singh","family":"Mann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5802-2291","authenticated-orcid":false,"given":"Ahmed Farid","family":"Gadelmawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Dway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathima Hayathi","family":"Fayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni Asfaw","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandha Kumar","family":"Varadharaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Akram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneeza","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uchechi Blessing","family":"Azuwike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharath Kanumuri","family":"Sampangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7888-8279","authenticated-orcid":false,"given":"Oluwaseun Adeolu","family":"Ogundijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuroscience.2026.05.044_b0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/can.2018.0050","article-title":"Treatment of gilles de la Tourette syndrome with cannabis-based medicine: results from a retrospective analysis and online survey","volume":"4","author":"Milosev","year":"2019","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.neuroscience.2026.05.044_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115135","article-title":"CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders \u2013 results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study","volume":"323","author":"M\u00fcller-Vahl","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuroscience.2026.05.044_b0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2022.08.010","article-title":"Systematic review and meta-analysis of tourette syndrome prevalence; 1986 to 2022","volume":"137","author":"Jafari","year":"2022","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuroscience.2026.05.044_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109675","article-title":"Meta-analysis: adulthood prevalence of Tourette syndrome","volume":"95","author":"Levine","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.05.044_b0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bj.2022.01.008","article-title":"Current understanding of the genetics of Tourette syndrome","volume":"45","author":"Lin","year":"2022","journal-title":"Biomed J."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.05.044_b0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1901\/jaba.2001.34-353","article-title":"Analyzing the influence of tic-related talk on vocal and motor tics in children with Tourette\u2019s syndrome","volume":"34","author":"Woods","year":"2001","journal-title":"J. Appl. Behav. Anal."},{"key":"10.1016\/j.neuroscience.2026.05.044_b0035","series-title":"Tourette Syndrome","author":"Olive","year":"2010"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.05.044_b0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/brain\/awu311","article-title":"Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome","volume":"138","author":"Worbe","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2026.05.044_b0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.12688\/f1000research.7424.1","article-title":"Recent advances in understanding and managing Tourette syndrome","volume":"5","author":"Thenganatt","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.neuroscience.2026.05.044_b0050","series-title":"International Review of Movement Disorders","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/bs.irmvd.2021.11.001","article-title":"Mechanistic insight into the pathophysiological basis of Tourette syndrome","author":"Rae","year":"2022"},{"issue":"13","key":"10.1016\/j.neuroscience.2026.05.044_b0055","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/0883073819862121","article-title":"Controversies surrounding the pathophysiology of tics","volume":"34","author":"Singer","year":"2019","journal-title":"J. Child Neurol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.05.044_b0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/cap.2009.0118","article-title":"Neurobiological substrates of Tourette\u2019s disorder","volume":"20","author":"Leckman","year":"2010","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.05.044_b0065","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpsychores.2009.06.006","article-title":"The genetics of Tourette syndrome: a review","volume":"67","author":"O\u2019Rourke","year":"2009","journal-title":"J. Psychosom. Res."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.05.044_b0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.mp.4000972","article-title":"Is Tourette\u2019s syndrome an autoimmune disease?","volume":"7","author":"Hoekstra","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.05.044_b0075","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1111\/ene.14983","article-title":"Immunity and Gilles de la Tourette syndrome: a systematic review and meta-analysis of evidence for immune implications in Tourette syndrome","volume":"28","author":"Lamothe","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.05.044_b0080","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.neubiorev.2012.10.010","article-title":"Environmental factors in Tourette syndrome","volume":"37","author":"Hoekstra","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuroscience.2026.05.044_b0085","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.28575","article-title":"Tics and Tourette syndrome: a literature review of etiological, clinical, and pathophysiological aspects","author":"Ramteke","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.05.044_b0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2013\/732038","article-title":"Health-related quality of life in Gilles de la Tourette syndrome: a decade of research","volume":"27","author":"Cavanna","year":"2013","journal-title":"Behav. Neurol."},{"issue":"3\u20134","key":"10.1016\/j.neuroscience.2026.05.044_b0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jocn.13074","article-title":"\u2018Living with tics\u2019: self-experience of adolescents with Tourette syndrome during peer interaction","volume":"25","author":"Lee","year":"2016","journal-title":"J. Clin. Nurs."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.05.044_b0100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2214.2009.00983.x","article-title":"The quality of life of young people with Tourette syndrome","volume":"35","author":"Cutler","year":"2009","journal-title":"Child Care Health Dev."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.05.044_b0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10447-013-9193-9","article-title":"The impact of Tourette\u2019s syndrome in the school and the family: perspectives from three stakeholder groups","volume":"36","author":"Rivera-Navarro","year":"2014","journal-title":"Int. J. Adv. Couns."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.05.044_b0110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s10597-011-9465-y","article-title":"The impact of Tourette syndrome in adults: results from the Tourette syndrome impact survey","volume":"49","author":"Conelea","year":"2013","journal-title":"Community Ment. Health J."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.05.044_b0115","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s10072-015-2223-0","article-title":"Tourette syndrome and socioeconomic status","volume":"36","author":"Aldred","year":"2015","journal-title":"Neurol. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2026.05.044_b0120","doi-asserted-by":"crossref","first-page":"I60","DOI":"10.1007\/s007870070020","article-title":"Gilles de la Tourette syndrome: symptomatic treatment based on evidence","volume":"9","author":"Robertson","year":"2000","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.05.044_b0125","first-page":"593","article-title":"Antipsychotics in the treatment of Tourette disorder: a review","volume":"50","author":"Cath","year":"2008","journal-title":"Tijdschr Voor Psychiatr."},{"key":"10.1016\/j.neuroscience.2026.05.044_b0130","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5141773","article-title":"Medical cannabis for gilles de la Tourette syndrome: an open-label prospective study","volume":"2022","author":"Anis","year":"2022","journal-title":"Behav. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.05.044_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e12874","article-title":"Emerging therapies and recent advances for Tourette syndrome","volume":"9","author":"Chou","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.05.044_b0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/WNF.0000000000000017","article-title":"A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome","volume":"37","author":"Gilbert","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuroscience.2026.05.044_b0145","unstructured":"Safety and efficacy study of NBI-98854 in adults with Tourette syndrome. https:\/\/clinicaltrials.gov\/show\/NCT02581865."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.05.044_b0150","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.brs.2014.11.015","article-title":"Randomized sham controlled double-blind trial of repetitive transcranial magnetic stimulation for adults with severe Tourette syndrome","volume":"8","author":"Landeros-Weisenberger","year":"2015","journal-title":"Brain Stimul."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.05.044_b0155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0145445514531015","article-title":"Negative reinforcement and premonitory urges in youth with Tourette syndrome: an experimental evaluation","volume":"38","author":"Capriotti","year":"2014","journal-title":"Behav. Modif."},{"key":"10.1016\/j.neuroscience.2026.05.044_b0160","doi-asserted-by":"crossref","unstructured":"Reese HE, Vallejo Z, Rasmussen J, Crowe K, Rosenfield E, Wilhelm S. Mindfulness-based stress reduction for Tourette Syndrome and Chronic Tic Disorder: a pilot study. Doi: 10.1016\/j.jpsychores.2014.08.001.","DOI":"10.1016\/j.jpsychores.2014.08.001"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.05.044_b0165","first-page":"213","article-title":"Cannabinoid modulation of immune mechanisms in Tourette syndrome","volume":"8","author":"Piscura","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.neuroscience.2026.05.044_b0170","series-title":"StatPearls","article-title":"Medical cannabis use in oncology","author":"Bodine","year":"2024"},{"issue":"7","key":"10.1016\/j.neuroscience.2026.05.044_b0175","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.05.044_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173607","article-title":"A systematic review of cannabidiol trials in neurodevelopmental disorders","volume":"230","author":"Parrella","year":"2023","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.neuroscience.2026.05.044_b0185","article-title":"Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review","author":"Rice","year":"2023","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"19","key":"10.1016\/j.neuroscience.2026.05.044_b0190","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0000000000007466","article-title":"Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders","volume":"92","author":"Pringsheim","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2026.05.044_b0195","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders: summary statement","author":"M\u00fcller-Vahl","year":"2021","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.05.044_b0200","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/appi.neuropsych.16110310","article-title":"Preliminary evidence on cannabis effectiveness and tolerability for adults with Tourette syndrome","volume":"29","author":"Abi-Jaoude","year":"2017","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.05.044_b0205","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1176\/appi.neuropsych.19080178","article-title":"A phase-2 pilot study of a therapeutic combination of \u03b49-tetrahydrocannabinol and palmitoylethanolamide for adults with Tourette\u2019s syndrome","volume":"33","author":"Bloch","year":"2021","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.05.044_b0210","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300012","article-title":"Tetrahydrocannabinol and cannabidiol in Tourette syndrome","volume":"2","author":"Mosley","year":"2023","journal-title":"NEJM Evidence"},{"key":"10.1016\/j.neuroscience.2026.05.044_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115135","article-title":"CANNA-TICS: efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders \u2013 results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study","volume":"323","author":"M\u00fcller-Vahl","year":"2023","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.05.044_b0220","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial","volume":"64","author":"M\u00fcller-Vahl","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.05.044_b0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette\u2019s syndrome with \u03949-tetrahydrocannabinol (THC): a randomized crossover trial","volume":"35","author":"M\u00fcller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.05.044_b0230","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jpsychores.2009.08.001","article-title":"Neuropsychological aspects of Tourette syndrome: a review","volume":"67","author":"Eddy","year":"2009","journal-title":"J. Psychosom. Res."},{"issue":"17","key":"10.1016\/j.neuroscience.2026.05.044_b0235","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","article-title":"Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"82","author":"Koppel","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.05.044_b0240","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1600-0447.1998.tb10127.x","article-title":"Cannabinoids: possible role in pathophysiology and therapy of Gilles de la Tourette syndrome","volume":"98","author":"M\u00fcller-Vahl","year":"1998","journal-title":"Acta Psychiatr. Scand."},{"issue":"24","key":"10.1016\/j.neuroscience.2026.05.044_b0245","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuroscience.2026.05.044_b0250","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2019"},{"key":"10.1016\/j.neuroscience.2026.05.044_b0255","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","first-page":"241","article-title":"Cochrane Statistical Methods Group. Analysing data and undertaking meta\u2010analyses","author":"Deeks","year":"2019"},{"issue":"19","key":"10.1016\/j.neuroscience.2026.05.044_b0260","doi-asserted-by":"crossref","first-page":"e1711","DOI":"10.1212\/WNL.0000000000005474","article-title":"A multicenter examination and strategic revisions of the Yale Global Tic Severity Scale","volume":"90","author":"McGuire","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2026.05.044_b0265","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00702-009-0353-3","article-title":"Tic disorders and the premonitory urge","volume":"117","author":"Steinberg","year":"2010","journal-title":"J. Neural Transm."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226003672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226003672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:50:27Z","timestamp":1783003827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226003672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":53,"alternative-id":["S0306452226003672"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.05.044","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabis for tic control: a systematic review and meta-analysis of its efficacy in Tourette syndrome management","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.05.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}